Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.

Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P.

Eur J Gastroenterol Hepatol. 2019 May;31(5):626-632. doi: 10.1097/MEG.0000000000001342.

PMID:
30550458
2.

Impact of short-term exercise training intensity on β-cell function in older obese adults with prediabetes.

Malin SK, Francois ME, Eichner NZM, Gilbertson NM, Heiston EM, Fabris C, Breton M.

J Appl Physiol (1985). 2018 Dec 1;125(6):1979-1986. doi: 10.1152/japplphysiol.00680.2018. Epub 2018 Oct 11.

3.

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.

Breton MD, Patek SD, Lv D, Schertz E, Robic J, Pinnata J, Kollar L, Barnett C, Wakeman C, Oliveri M, Fabris C, Chernavvsky D, Kovatchev BP, Anderson SM.

Diabetes Technol Ther. 2018 Aug;20(8):531-540. doi: 10.1089/dia.2018.0079. Epub 2018 Jul 6.

4.

Combining Short-Term Interval Training with Caloric Restriction Improves ß-Cell Function in Obese Adults.

Francois ME, Gilbertson NM, Eichner NZM, Heiston EM, Fabris C, Breton M, Mehaffey JH, Hassinger T, Hallowell PT, Malin SK.

Nutrients. 2018 Jun 3;10(6). pii: E717. doi: 10.3390/nu10060717.

5.

Recent Exposure to Hypoglycemia Increases Glucose Variability Following a Hyper/Hypoglycemic Metabolic Challenge in T1D.

Fabris C, Farhy LS, Anderson SM, Nass RM, Kovatchev BP, Breton MD.

J Diabetes Sci Technol. 2018 Mar;12(2):311-317. doi: 10.1177/1932296817729392. Epub 2017 Sep 25.

6.

Exploring the Frequency Domain of Continuous Glucose Monitoring Signals to Improve Characterization of Glucose Variability and of Diabetic Profiles.

Fico G, Hernández L, Cancela J, Isabel MM, Facchinetti A, Fabris C, Gabriel R, Cobelli C, Arredondo Waldmeyer MT.

J Diabetes Sci Technol. 2017 Jul;11(4):773-779. doi: 10.1177/1932296816685717. Epub 2017 Jan 9.

7.

Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β2 Adrenergic Receptor Ligands.

Martin C, Moors SLC, Danielsen M, Betti C, Fabris C, Sejer Pedersen D, Pardon E, Peyressatre M, Fehér K, Martins JC, Mosolff Mathiesen J, Morris MC, Devoogdt N, Caveliers V, De Proft F, Steyaert J, Ballet S.

Chemistry. 2017 Jul 18;23(40):9632-9640. doi: 10.1002/chem.201701321. Epub 2017 Jun 29.

PMID:
28449310
8.

Reply to the letter to the Editor.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Nov-Dec;15(6):947-948. No abstract available.

9.

Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization.

Zarpelon CS, Netto MC, Jorge JC, Fabris CC, Desengrini D, Jardim Mda S, Silva DG.

Arq Bras Cardiol. 2016 Jul;107(1):4-9. doi: 10.5935/abc.20160082. Epub 2016 May 24. English, Portuguese.

10.

Congenital intrahepatic portosystemic shunt diagnosed during intrauterine life.

Bellettini CV, Wagner R, Sette Balzanelo A, de Souza Andretta AL, Nascimento de Moura A, Fabris CC, Maranhão Gubert E.

Rev Paul Pediatr. 2016 Sep;34(3):384-7. doi: 10.1016/j.rpped.2016.03.003. Epub 2016 Apr 8. English, Portuguese.

11.

In Situ and In Vitro Effects of Two Bleaching Treatments on Human Enamel Hardness.

Henn-Donassollo S, Fabris C, Gagiolla M, Kerber Í, Caetano V, Carboni V, Salas MM, Donassollo TA, Demarco FF.

Braz Dent J. 2016 Jan-Feb;27(1):56-9. doi: 10.1590/0103-6440201600385.

12.

 Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Mar-Apr;15(2):200-6. doi: 10.5604/16652681.1193710.

13.

Reply to the letter to the Editor.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Nov - Dec;15(6):947-948. doi: 10.5604/16652681.1222120. No abstract available.

14.

Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

Bignulin S, Falleti E, Cmet S, Cappello D, Cussigh A, Lenisa I, Dissegna D, Pugliese F, Vivarelli C, Fabris C, Toniutto P.

Ann Hepatol. 2016 Mar - Apr;15(2):200-206. doi: 10.5604/16652681.1193710.

15.

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.

Falleti E, Cussigh A, Cmet S, Fabris C, Toniutto P.

Dig Liver Dis. 2016 Jan;48(1):69-75. doi: 10.1016/j.dld.2015.09.009. Epub 2015 Sep 28.

PMID:
26493626
16.

Are Risk Indices Derived From CGM Interchangeable With SMBG-Based Indices?

Fabris C, Patek SD, Breton MD.

J Diabetes Sci Technol. 2015 Aug 14;10(1):50-9. doi: 10.1177/1932296815599177.

17.

Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.

Fabris C, Facchinetti A, Fico G, Sambo F, Arredondo MT, Cobelli C; MOSAIC EU Project Consortium.

J Diabetes Sci Technol. 2015 Jul 31;10(1):119-24. doi: 10.1177/1932296815596173.

18.

Sparse Principal Component Analysis for the parsimonious description of glucose variability in diabetes.

Fabris C, Facchinetti A, Sparacino G, Cobelli C.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:6643-6. doi: 10.1109/EMBC.2014.6945151.

PMID:
25571519
19.

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.

Toniutto P, Bitetto D, Falleti E, Vadalà S, Cmet S, Cussigh A, Bulajic M, Zilli M, Fabris C.

Int J Surg. 2014 Oct;12(10):1082-7. doi: 10.1016/j.ijsu.2014.09.004. Epub 2014 Sep 16.

20.

Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.

Fabris C, Facchinetti A, Sparacino G, Zanon M, Guerra S, Maran A, Cobelli C.

Diabetes Technol Ther. 2014 Oct;16(10):644-52. doi: 10.1089/dia.2013.0252. Epub 2014 Jun 23.

PMID:
24956070
21.

Hypoglycemia-related electroencephalogram changes assessed by multiscale entropy.

Fabris C, Sparacino G, Sejling AS, Goljahani A, Duun-Henriksen J, Remvig LS, Juhl CB, Cobelli C.

Diabetes Technol Ther. 2014 Oct;16(10):688-94. doi: 10.1089/dia.2013.0331. Epub 2014 Jun 3. Review.

PMID:
24892361
22.

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Fattovich G, Cussigh A, Bitetto D, Ceriani E, Lenisa I, Dissegna D, Ieluzzi D, Rostello A, Pirisi M, Toniutto P.

PLoS One. 2013 Nov 14;8(11):e80764. doi: 10.1371/journal.pone.0080764. eCollection 2013.

23.

Detection of bovine alpha-S1-casein in term and preterm human colostrum with proteomic techniques.

Orru S, Di Nicola P, Giuliani F, Fabris C, Conti A, Coscia A, Bertino E.

Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):435-44.

PMID:
23755758
24.

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Bitetto D, De Feo T, Mantovani M, Falleti E, Fabris C, Belli LS, Fagiuoli S, Burra P, Piccolo G, Donato MF, Toniutto P; AISF RECOLT Study Group, Cmet S, Cussigh A, Viganò R, Airoldi A, Pasulo L, Colpanij M, De Martin E, Gambato M, Rigamonti C.

Dig Liver Dis. 2013 Nov;45(11):927-32. doi: 10.1016/j.dld.2013.04.006. Epub 2013 May 27.

PMID:
23722013
25.

Reply: To PMID 22610885.

Falleti E, Fabris C, Toniutto P.

Hepatology. 2013 Nov;58(5):1864-5. doi: 10.1002/hep.26435. Epub 2013 Sep 13. No abstract available.

PMID:
23553733
26.

Communication in NICUs.

Coscia A, Martano C, Cresi F, Tonetto P, Giuliani F, Forno M, Quadrino S, Mombrò M, Fabris C.

J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3 Suppl):31-3. Review.

PMID:
23158511
27.

Metabolism and biological functions of human milk oligosaccharides.

Bertino E, Peila C, Giuliani F, Martano C, Cresi F, Di Nicola P, Occhi L, Sabatino G, Fabris C.

J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3 Suppl):35-8. Review.

PMID:
23158512
28.

Auxological evaluation of newborns.

Bertino E, Coscia A, Occhi L, Di Nicola P, Fabris C, Varalda A, Giuliani F, Sabatino G, Vassia C, Gilli G.

J Biol Regul Homeost Agents. 2012 Jul-Sep;26(3 Suppl):15-7.

PMID:
23158508
29.

Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy.

Bitetto D, Bortolotti N, Falleti E, Vescovo S, Fabris C, Fattovich G, Cussigh A, Cmet S, Fornasiere E, Ceriani E, Pirisi M, Toniutto P.

Hepatology. 2013 Mar;57(3):925-33. doi: 10.1002/hep.26186. Epub 2013 Feb 7.

PMID:
23213086
30.

Survival of lupus patients on dialysis: a Brazilian cohort.

Ribeiro FM, Fabris CL, Bendet I, Lugon JR.

Rheumatology (Oxford). 2013 Mar;52(3):494-500. doi: 10.1093/rheumatology/kes298. Epub 2012 Nov 12.

PMID:
23148092
31.

Toll like receptor 4 D299G associates with disease progression in Caucasian patients with chronic HBV infection: relationship with gender.

Cussigh A, Fabris C, Fattovich G, Falleti E, Cmet S, Bitetto D, Bignulin E, Toniutto P.

J Clin Immunol. 2013 Feb;33(2):313-6. doi: 10.1007/s10875-012-9822-9. Epub 2012 Oct 24.

PMID:
23093310
32.

Detection of cow's milk proteins and minor components in human milk using proteomics techniques.

Coscia A, Orrù S, Di Nicola P, Giuliani F, Varalda A, Peila C, Fabris C, Conti A, Bertino E.

J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:54-6. doi: 10.3109/14767058.2012.715015.

PMID:
22958018
33.

Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.

Marengo A, Bitetto D, D'Avolio A, Ciancio A, Fabris C, Marietti M, Toniutto P, Di Perri G, Rizzetto M, Marzano A.

Antivir Ther. 2013;18(1):87-94. doi: 10.3851/IMP2284. Epub 2012 Aug 7.

PMID:
22872649
34.

Efficacy of sunlight-activatable porphyrin formulates on larvae of Anopheles gambiae M and S molecular forms and An. arabiensis: a potential novel biolarvicide for integrated malaria vector control.

Fabris C, Ouédraogo RK, Coppellotti O, Dabiré RK, Diabaté A, Di Martino P, Guidolin L, Jori G, Lucantoni L, Lupidi G, Martena V, Sawadogo SP, Soncin M, Habluetzel A.

Acta Trop. 2012 Sep;123(3):239-43. doi: 10.1016/j.actatropica.2012.05.011. Epub 2012 Jun 2.

PMID:
22668835
35.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, Ceriani E, Fornasiere E, Pasino M, Ieluzzi D, Pirisi M, Toniutto P.

Hepatology. 2012 Nov;56(5):1641-50. doi: 10.1002/hep.25848. Epub 2012 Oct 14.

PMID:
22610885
36.

Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.

Bitetto D, Fabris C, Falleti E, Fornasiere E, Avellini C, Cmet S, Cussigh A, Fontanini E, Pirisi M, Corradini SG, Merli M, Molinaro A, Toniutto P.

Transplantation. 2012 May 27;93(10):1038-44. doi: 10.1097/TP.0b013e31824df7f3.

PMID:
22495472
37.

The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Colletta C, Vandelli C, Cmet S, Ceriani E, Smirne C, Toniutto P, Pirisi M.

J Med Virol. 2012 May;84(5):747-55. doi: 10.1002/jmv.23259.

PMID:
22431022
38.

Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.

Cmet S, Fabris C, Fattovich G, Falleti E, Bitetto D, Cussigh A, Fontanini E, Fornasiere E, Pirisi M, Toniutto P.

Clin Exp Immunol. 2012 Feb;167(2):296-302. doi: 10.1111/j.1365-2249.2011.04497.x.

39.

Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients.

Falleti E, Bitetto D, Fabris C, Cmet S, Fornasiere E, Cussigh A, Fontanini E, Avellini C, Barbina G, Ceriani E, Pirisi M, Toniutto P.

Transpl Int. 2012 Mar;25(3):314-22. doi: 10.1111/j.1432-2277.2011.01419.x. Epub 2012 Jan 3.

40.

Porphyrin photosensitised processes in the prevention and treatment of water- and vector-borne diseases.

Coppellotti O, Fabris C, Soncin M, Magaraggia M, Camerin M, Jori G, Guidolin L.

Curr Med Chem. 2012;19(6):808-19. Review.

PMID:
22214456
41.

Novel, meso-substituted cationic porphyrin molecule for photo-mediated larval control of the dengue vector Aedes aegypti.

Lucantoni L, Magaraggia M, Lupidi G, Ouedraogo RK, Coppellotti O, Esposito F, Fabris C, Jori G, Habluetzel A.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1434. doi: 10.1371/journal.pntd.0001434. Epub 2011 Dec 20.

42.

Photodynamic inactivation of microbial pathogens: disinfection of water and prevention of water-borne diseases.

Jori G, Magaraggia M, Fabris C, Soncin M, Camerin M, Tallandini L, Coppellotti O, Guidolin L.

J Environ Pathol Toxicol Oncol. 2011;30(3):261-71.

PMID:
22126619
43.

Preterm milk oligosaccharides during the first month of lactation.

Gabrielli O, Zampini L, Galeazzi T, Padella L, Santoro L, Peila C, Giuliani F, Bertino E, Fabris C, Coppa GV.

Pediatrics. 2011 Dec;128(6):e1520-31. doi: 10.1542/peds.2011-1206. Epub 2011 Nov 28.

PMID:
22123889
44.

Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.

Falleti E, Cmet S, Fabris C, Bitetto D, Cussigh A, Fornasiere E, Bignulin E, Feruglio C, Mosanghini E, Fontanini E, Pirisi M, Toniutto P.

Cytokine. 2012 Jan;57(1):68-73. doi: 10.1016/j.cyto.2011.10.018. Epub 2011 Nov 27.

PMID:
22122913
45.

Effects of a new photoactivatable cationic porphyrin on ciliated protozoa and branchiopod crustaceans, potential components of freshwater ecosystems polluted by pathogenic agents and their vectors.

Fabris C, Soncin M, Jori G, Habluetzel A, Lucantoni L, Sawadogo S, Guidolin L, Coppellotti O.

Photochem Photobiol Sci. 2012 Feb;11(2):294-301. doi: 10.1039/c1pp05154g. Epub 2011 Oct 20.

PMID:
22011789
46.

Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis.

Luzzati R, Confalonieri M, Cazzadori A, Della Loggia P, Cifaldi R, Fabris C, Biolo M, Borelli M, Longo C, Concia E.

Monaldi Arch Chest Dis. 2011 Jun;75(2):141-5.

47.

Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.

Minisini R, Giarda P, Grossi G, Bitetto D, Toniutto P, Falleti E, Avellini C, Occhino G, Fabris C, Pirisi M.

J Gastroenterol. 2011 Nov;46(11):1307-15. doi: 10.1007/s00535-011-0440-8. Epub 2011 Jul 23.

PMID:
21789480
48.

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.

Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P.

Liver Int. 2011 Sep;31(8):1137-43. doi: 10.1111/j.1478-3231.2011.02534.x. Epub 2011 Apr 19.

PMID:
21745286
49.

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

Falleti E, Bitetto D, Fabris C, Cussigh A, Fornasiere E, Cmet S, Fumolo E, Bignulin S, Fontanini E, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Clin Immunol. 2011 Oct;31(5):891-9. doi: 10.1007/s10875-011-9547-1. Epub 2011 Jun 7.

PMID:
21647799
50.

Reference values of blood cell counts in the first days of life.

Melioli G, Risso FM, Sannia A, Serra G, Bologna R, Mussap M, Mangraviti S, Fortini P, Facco F, Reggiardo G, Buonocore G, Corsello G, Fanos V, Del Vecchio A, Fabris C, Gazzolo D.

Front Biosci (Elite Ed). 2011 Jun 1;3:871-8.

PMID:
21622098

Supplemental Content

Loading ...
Support Center